Is HIV Therapy Good Enough or Do We Still Need New Drugs?
| Overview / Abstract: |
Learning Objectives Discuss the rationale for continued drug development in the era of well tolerated, single-tablet regimens The content for this activity is drawn from the 11th Annual American Conference for the Treatment of HIV (ACTHIV 2018). |
|
Expiration |
Sep 15, 2018 |
|
Discipline(s) |
Nurse Practitioner , Nursing CNE, Pharmacy CPE, Physician CME, Physician Assistant CME, Social Work CE |
|
Format |
Webinar / Webcast / Video |
|
Credits / Hours |
0.75 |
|
Accreditation |
ACCME, ANCC |
|
Presenters / Authors / Faculty |
Joel E. Gallant, MD, MPH, Medical Director of Specialty Services at Southwest CARE Center in Santa Fe, New Mexico |
|
Activity Specialities / Related Topics |
Family Medicine, HIV / AIDS, Infectious Disease, Internal Medicine, OB/GYN / Women's Health, Pharmacology, Primary Care |
|
Sponsors / Supporters / Grant Providers |
The 11th Annual American Conference for the Treatment of HIV (ACTHIV) was held April 20-22, 2017 in Dallas, TX. The Conference was supported by funding from the Clinical Education Initiative, New York State Department of Health, AIDS Institute; and from the HIV Medicine Association (HIVMA). The conference and this web archive were supported by educational grants from Bristol-Myers Squibb; Gilead Sciences; Janssen Therapeutics, Division of Janssen Products, LP; Merck & Co.; and ViiV Healthcare. |
|
Keywords / Search Terms |
American Academy of CME HIV, AIDS, ACTHIV, American Conference for the Treatment of HIV, Infectious Disease, CME, CNE, CE, ART, antiretroviral therapy, Free CE CME |
|